Five months after announcing it, GlaxoSmithKline confirmed it has completed the spin-off of its consumer division, which is now officially operating as Haleon. The name change applies to Glaxo’s manufacturing plant in Guayama. The new independent company is 100% focused on consumer health, completing its demerger from GSK. Haleon is the maker of recognized brands […]
Business is on track to spin-off the unit and list it as a new company in mid-2022.